SPC347
Selinexor eða lyfjafræðilega viðunandi salt þar af
Status:
VeittApplication date:
30.8.2021Application published:
15.9.2021Grant published:
15.12.2022
Max expiry date:
28.3.2036Medicine name:
NEXPOVIOMedicine for children:
No
Timeline
Today
30.8.2021Application
15.9.2021Publication
15.12.2022Registration
28.3.2036Expires
Marketing license
IS authorization number:
EU/1/21/1537/001-004Date:
30.3.2021
Foreign authorization number:
EU/1/21/1537Date:
26.3.2021
Owner
Name:
Karyopharm Therapeutics Inc.Address:
85 Wells Avenue, 2nd Floor, Newton, MA 02459 US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105 Reykjavík
Patent
Number:
EP2736887